학술논문
Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial
Document Type
Article
Author
Harkness, Kirsty; Kuruvilla, Tarun; McShane, Rupert; Connelly, Peter; Duncan, Gordon; Calvert, Lucy; Lawrie, Alasdair; Sheridan, Matthew; Jackson, Eric; Udeze, Bernard; Pearson, Stephen; Langheinrich, Tobias; Wagle, Suvarna; Butchart, Joseph; Macharouthu, Ajay; Donaldson, Andrew; Neil, Wendy; Pattan, Vivek; Findlay, David; Thomas, Alan; Barber, Robert; Byrne, Andrew; Dalvi, Madhusudan; Negi, Rashi; McGuinness, Bernadette; Kehoe, Patrick Gavin ; Turner, Nicholas; Howden, Beth; Jarutyte, Lina; Clegg, Shona Louise; Malone, Ian Brian; Barnes, Josephine; Nielsen, Casper; Sudre, Carole Hélène; Wilson, Aileen; Thai, Ngoc Jade; Blair, Peter Sinclair; Coulthard, Elizabeth; Lane, Janet Athene; Passmore, Peter; Taylor, Jodi; Mutsaerts, Henk-Jan; Thomas, David Lee; Fox, Nick Charles; Wilkinson, Ian; Ben-Shlomo, Yoav
Source
In The Lancet Neurology November 2021 20(11):895-906
Subject
Language
ISSN
1474-4422